Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
Clinical trial NCT00356564 · COMPLETED
Trial details
- NCT number
- NCT00356564
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.